Comparison of effects of repaglinide and nateglinide on insulin secretion and postloading glucose excursions in patients with Type 2 diabetes.

被引：0
|
作者：
Rudovich, NN
Dieken, MHL
Pfeiffer, AFH
机构：
[1] Free Univ Berlin, Klinikum B Franklin, Dept Internal Med, Div Endocrinol, Berlin, Germany
[2] Novo Nordisk Pharma GmbH, Mainz, Germany
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
764
引用
收藏
页码：A245 / A245
页数：1
相关论文
共 50 条
  • [1] Comparison of effects of repaglinide and nateglinide on insulin secretion and postloading glucose excursions in patients with Type 2 diabetes.
    Rudovich, NN
    Rochlitz, H
    Dieken, MGL
    Pfeiffer, AFH
    [J]. DIABETOLOGIA, 2003, 46 : A282 - A283
  • [2] Comparison of effects of repaglinide and nateglinide on insulin secretion and postloading glucose excursions in patients with type 2 diabetes
    Rudovich, N
    Rochlitz, H
    Dieken, ML
    Pfeiffer, A
    [J]. DIABETES, 2003, 52 : A454 - A454
  • [3] Nateglinide enhances first phase insulin secretion and glucose clearance in type 2 diabetes.
    Kahn, SE
    Montgomery, B
    Ligueros-Saylan, M
    Hsu, C
    Devineni, D
    Mcleod, JF
    Horowitz, AD
    [J]. DIABETOLOGIA, 2000, 43 : A187 - A187
  • [4] Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study
    Rizzo, MR
    Barbieri, M
    Grella, R
    Passariello, N
    Barone, M
    Paolisso, G
    [J]. DIABETES & METABOLISM, 2004, 30 (01) : 81 - 89
  • [5] Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes
    Lindsay, JR
    McKillop, AM
    Mooney, MH
    O'Harte, FPM
    Flatt, PR
    Bell, PM
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (03) : 167 - 173
  • [6] Repaglinide plus metformin: Therapy effects on insulin secretion and sensitivity in type 2 diabetes.
    Roudovitch, N
    Dicken, ML
    Pfeiffer, AFH
    [J]. DIABETOLOGIA, 2001, 44 : A235 - A235
  • [7] The improvement of early phase of insulin secretion after glucose load with nateglinide in patients with type 2 diabetes
    Mori, Y
    Ishii, H
    Hikita, M
    Yokoyama, J
    Tajima, N
    [J]. DIABETES, 2001, 50 : A127 - A127
  • [8] Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus
    Keilson, L
    Mather, S
    Walter, YH
    Subramanian, S
    McLeod, JF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1081 - 1086
  • [9] Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes
    Ai, M
    Tanaka, A
    Ogita, K
    Shimokado, K
    [J]. DIABETES CARE, 2006, 29 (05) : 1180 - 1180
  • [10] Insulin action and secretion in offspring of patients with type 2 diabetes.
    Volk, A
    Renn, W
    Maerker, E
    Dahl, B
    Haap, M
    Häring, HU
    Rett, K
    [J]. DIABETOLOGIA, 1998, 41 : A195 - A195
12345